-
1
-
-
0034672781
-
Evaluating effectiveness of syringe exchange programs: Current issues and future prospects
-
Bastos, F. I., and Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programs: Current issues and future prospects. Social Science and Medicine, 51, 1771-1782.
-
(2000)
Social Science and Medicine
, vol.51
, pp. 1771-1782
-
-
Bastos, F.I.1
Strathdee, S.A.2
-
2
-
-
27744546784
-
Injecting drug users and HIV vaccine trials: What does the science say?
-
Beyrer, C. (2002). Injecting drug users and HIV vaccine trials: What does the science say? AIDScience, 2(14), 1-6.
-
(2002)
AIDScience
, vol.2
, Issue.14
, pp. 1-6
-
-
Beyrer, C.1
-
3
-
-
2142705712
-
Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation
-
Buchbinder, S. P., Metch, B., Holte, S. E., Scheer, S., Coletti, A., and Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604-612.
-
(2004)
Journal of Acquired Immune Deficiency Syndromes
, vol.36
, Issue.1
, pp. 604-612
-
-
Buchbinder, S.P.1
Metch, B.2
Holte, S.E.3
Scheer, S.4
Coletti, A.5
Vittinghoff, E.6
-
4
-
-
27744431906
-
-
Centers for Disease Control and Prevention. (2001). HIV/AIDS surveillance Report, 13(2), 19-21.
-
(2001)
HIV/AIDS Surveillance Report
, vol.13
, Issue.2
, pp. 19-21
-
-
-
5
-
-
0030001395
-
HIV epidemiology and interventions among injecting drug users
-
Des Jarlais, D. C., and Friedman, S. R. (1996). HIV epidemiology and interventions among injecting drug users. International Journal of STD and AIDS, 7(Suppl 2), 57-61.
-
(1996)
International Journal of STD and AIDS
, vol.7
, Issue.2 SUPPL.
, pp. 57-61
-
-
Des Jarlais, D.C.1
Friedman, S.R.2
-
6
-
-
0027173666
-
Community development as a response to HIV among drug injectors
-
Friedman, S. R., de Jong, W., and Wodak, A. (1993). Community development as a response to HIV among drug injectors. AIDS, 7(Suppl. 1), S263-S269.
-
(1993)
AIDS
, vol.7
, Issue.1 SUPPL.
-
-
Friedman, S.R.1
De Jong, W.2
Wodak, A.3
-
8
-
-
0028788544
-
Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial
-
Harrison, K., Vlahov, D., Jones, K., Charron, K., and Clements, M. L. (1995). Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 386-390.
-
(1995)
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
, vol.10
, pp. 386-390
-
-
Harrison, K.1
Vlahov, D.2
Jones, K.3
Charron, K.4
Clements, M.L.5
-
9
-
-
0029991257
-
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas
-
Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86(5), 642-654.
-
(1996)
American Journal of Public Health
, vol.86
, Issue.5
, pp. 642-654
-
-
Holmberg, S.D.1
-
10
-
-
7144253781
-
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
-
Koblin, B. A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J., Gross, M., Marmor, M., Mayer, K., Metzger, D., and Seage, G. (1998). Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12, 785-793.
-
(1998)
AIDS
, vol.12
, pp. 785-793
-
-
Koblin, B.A.1
Heagerty, P.2
Sheon, A.3
Buchbinder, S.4
Celum, C.5
Douglas, J.6
Gross, M.7
Marmor, M.8
Mayer, K.9
Metzger, D.10
Seage, G.11
-
11
-
-
0034662728
-
Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials
-
Koblin, B. A., Holte, S., Lenerking, B., and Heagerty, P. (2000). Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. Journal of Acquired Immune Deficiency Syndromes, 24(5), 451-457.
-
(2000)
Journal of Acquired Immune Deficiency Syndromes
, vol.24
, Issue.5
, pp. 451-457
-
-
Koblin, B.A.1
Holte, S.2
Lenerking, B.3
Heagerty, P.4
-
12
-
-
0032318912
-
Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users' networks
-
Latkin, C. A. (1998). Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Reports, 113(Suppl. 1), 151-159.
-
(1998)
Public Health Reports
, vol.113
, Issue.1 SUPPL.
, pp. 151-159
-
-
Latkin, C.A.1
-
13
-
-
0031842469
-
Tuberculosis screening and compliance with return for skin test reading among active drug users
-
Malotte, C. K., Rhodes, F., and Mais, K. E. (1998). Tuberculosis screening and compliance with return for skin test reading among active drug users. American Journal of Public Health, 88(5), 792-796.
-
(1998)
American Journal of Public Health
, vol.88
, Issue.5
, pp. 792-796
-
-
Malotte, C.K.1
Rhodes, F.2
Mais, K.E.3
-
14
-
-
0027237484
-
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
-
Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., and Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6(9), 1049-1056.
-
(1993)
Journal of Acquired Immune Deficiency Syndromes
, vol.6
, Issue.9
, pp. 1049-1056
-
-
Metzger, D.S.1
Woody, G.E.2
McLellan, A.T.3
O'Brien, C.P.4
Druley, P.5
Navaline, H.6
DePhilippis, D.7
Stolley, P.8
Abrutyn, E.9
-
15
-
-
0028101848
-
HIV vaccine trials: Will intravenous drug users enroll?
-
Meyers, K., Metzger, D. S., Navaline, H., Woody, G. E., and McLellan, A. T. (1994). HIV vaccine trials: will intravenous drug users enroll? American Journal of Public Health, 84, 761-766.
-
(1994)
American Journal of Public Health
, vol.84
, pp. 761-766
-
-
Meyers, K.1
Metzger, D.S.2
Navaline, H.3
Woody, G.E.4
McLellan, A.T.5
-
16
-
-
0036784787
-
Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998
-
Nelson, K. E., Galai, N., Safaeian, M., Strathdee, S. A., Celentano, D. D., and Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. American Journal of Epidemiology, 156, 641-653.
-
(2002)
American Journal of Epidemiology
, vol.156
, pp. 641-653
-
-
Nelson, K.E.1
Galai, N.2
Safaeian, M.3
Strathdee, S.A.4
Celentano, D.D.5
Vlahov, D.6
-
17
-
-
0037114815
-
Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial
-
O'Connell, J. M., Hogg, R. S., Chan, K., Strathdee, S. A., McLean, N., Martindale, S. L., Willoughby, B., and Remis, R. (2002). Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. Journal of Acquired Immune Deficiency Syndromes, 31, 521-528.
-
(2002)
Journal of Acquired Immune Deficiency Syndromes
, vol.31
, pp. 521-528
-
-
O'Connell, J.M.1
Hogg, R.S.2
Chan, K.3
Strathdee, S.A.4
McLean, N.5
Martindale, S.L.6
Willoughby, B.7
Remis, R.8
-
18
-
-
0030978971
-
Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
-
Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G., Rekart, M. L., Montaner, J. S., Schechter, M. T., and O'Shaughnessy, M. V. (1997). Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11, F59-F65.
-
(1997)
AIDS
, vol.11
-
-
Strathdee, S.A.1
Patrick, D.M.2
Currie, S.L.3
Cornelisse, P.G.4
Rekart, M.L.5
Montaner, J.S.6
Schechter, M.T.7
O'Shaughnessy, M.V.8
-
19
-
-
0032511413
-
Barriers to use of free antiretroviral therapy in injection drug users
-
Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shaughnessy, M. V., Montaner, J. S., Schechter, M. T., and Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280, 547-549.
-
(1998)
JAMA
, vol.280
, pp. 547-549
-
-
Strathdee, S.A.1
Palepu, A.2
Cornelisse, P.G.3
Yip, B.4
O'Shaughnessy, M.V.5
Montaner, J.S.6
Schechter, M.T.7
Hogg, R.S.8
-
20
-
-
0033851956
-
Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men
-
Strathdee, S. A., Hogg, R., Cornelisse, P., Martindale, S., Currrie, S., O'Shaughnessy, M., and Schechter, M. (2000). Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men. AIDS and Behavior, 4(3), 271-278.
-
(2000)
AIDS and Behavior
, vol.4
, Issue.3
, pp. 271-278
-
-
Strathdee, S.A.1
Hogg, R.2
Cornelisse, P.3
Martindale, S.4
Currrie, S.5
O'Shaughnessy, M.6
Schechter, M.7
-
21
-
-
0035146849
-
Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities
-
Strauss, R. P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S., Khanani, F., Emrick, C. B., and MacQueen, K. M. (2001). Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(1), 63-71.
-
(2001)
Journal of Acquired Immune Deficiency Syndromes
, vol.26
, Issue.1
, pp. 63-71
-
-
Strauss, R.P.1
Sengupta, S.2
Kegeles, S.3
McLellan, E.4
Metzger, D.5
Eyre, S.6
Khanani, F.7
Emrick, C.B.8
MacQueen, K.M.9
-
22
-
-
0032537105
-
Maximum impact of HIV prevention measures targeted at injecting drug users
-
Van Ameijden, E. J., and Coutinho, R. A. (1998). Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS, 12, 625-633.
-
(1998)
AIDS
, vol.12
, pp. 625-633
-
-
Van Ameijden, E.J.1
Coutinho, R.A.2
-
23
-
-
0026357723
-
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants
-
Vlahov, D., Anthony, J. C., Muñoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., and Polk, B. F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monographs, 109, 75-100.
-
(1991)
NIDA Research Monographs
, vol.109
, pp. 75-100
-
-
Vlahov, D.1
Anthony, J.C.2
Muñoz, A.3
Margolick, J.4
Nelson, K.E.5
Celentano, D.D.6
Solomon, L.7
Polk, B.F.8
-
24
-
-
0028028083
-
Interest in HIV vaccines among injection drug users in Baltimore, Maryland
-
Vlahov, D., Astemborski, J., Solomon, L., Galai, N., Basarab, L., and Nelson, K. E. (1994). Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Research and Human Retroviruses, 70(Suppl. 2), S265-S268.
-
(1994)
AIDS Research and Human Retroviruses
, vol.70
, Issue.2 SUPPL.
-
-
Vlahov, D.1
Astemborski, J.2
Solomon, L.3
Galai, N.4
Basarab, L.5
Nelson, K.E.6
|